Arkolith/Insider Trading/CARA

CARA Insider Trading

Cara Therapeutics, Inc. · full profile →Last filing Jun 9, 2026

Cara Therapeutics, Inc. also files under TVRD; those filings are included.

Mixed · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$0
open market, 180d
Reporting Insiders
0
0 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

100 shown
DateInsiderRoleActionSharesPriceValue
Jun 9, 2026Smith CynthiaDirectorGrant(A)6K—$0
Jun 9, 2026Shiff Susan Ph.D.DirectorGrant(A)6K—$0
Jun 9, 2026Shah SujalDirectorGrant(A)6K—$0
Jun 9, 2026Hall Wallace L JRDirectorGrant(A)6K—$0
Jun 9, 2026Wyzga Michael SDirectorGrant(A)6K—$0
Jan 29, 2026Conn Avi DanielChief Financial OfficerGrant(A)45K—$0
Jan 29, 2026Kauh John Saewook M.D.Chief Medical OfficerGrant(A)45K—$0
Jan 29, 2026O'Brien Stephen PaulPrincipal Accounting OfficerGrant(A)15K—$0
Jan 29, 2026Alibhai Imran NizamudinChief Executive Officer, DirectorGrant(A)115K—$0
Dec 16, 2025Kauh John Saewook M.D.Chief Medical OfficerGrant(A)18K—$0
Dec 16, 2025Conn Avi DanielChief Financial OfficerGrant(A)18K—$0
Dec 16, 2025O'Brien Stephen PaulPrincipal Accounting OfficerGrant(A)4K—$0
Dec 16, 2025Alibhai Imran NizamudinChief Executive Officer, DirectorGrant(A)48K—$0
Jul 7, 2025Tweardy Samuel David10% OwnerOther(J)316K—$0
Jul 7, 2025Tweardy Samuel David10% OwnerOther(J)316K—$0
Apr 17, 2025Kauh John Saewook M.D.Chief Medical OfficerGrant(A)36K—$0
Apr 17, 2025Wyzga Michael SDirectorGrant(A)12K—$0
Apr 17, 2025Alibhai Imran NizamudinChief Executive Officer, DirectorGrant(A)182K—$0
Apr 17, 2025Smith CynthiaDirectorGrant(A)12K—$0
Apr 17, 2025Shiff Susan Ph.D.DirectorGrant(A)12K—$0
Apr 17, 2025Hall Wallace L JRDirectorGrant(A)12K—$0
Apr 17, 2025Shah SujalDirectorGrant(A)12K—$0
Apr 17, 2025O'Brien Stephen PaulPrincipal Accounting OfficerGrant(A)7K—$0
Apr 17, 2025Conn Avi DanielChief Financial OfficerGrant(A)44K—$0
Apr 17, 2025Chen YixinVP, Chem, Mfg and CtrlsGrant(A)7K—$0
Apr 17, 2025Wirk ShaheenDirectorGrant(A)12K—$0
Apr 17, 2025Larson Jeffrey LeroySVP, Research & DevelopmentGrant(A)11K—$0
Apr 15, 2025Conn Avi DanielChief Financial OfficerGrant(A)89K——
Apr 15, 2025Alibhai Imran NizamudinChief Executive Officer, DirectorGrant(A)208K——
Apr 15, 2025Alibhai Imran NizamudinChief Executive Officer, DirectorGrant(A)2K——
Apr 15, 2025Alibhai Imran NizamudinChief Executive Officer, DirectorGrant(A)161K——
Apr 15, 2025O'Brien Stephen PaulPrincipal Accounting OfficerGrant(A)3K——
Apr 15, 2025Larson Jeffrey LeroySVP, Research & DevelopmentGrant(A)17K——
Apr 15, 2025Kauh John Saewook M.D.Chief Medical OfficerGrant(A)74K——
Apr 15, 2025Wyzga Michael SDirectorGrant(A)18K——
Apr 15, 2025Hall Wallace L JRDirectorGrant(A)202K——
Apr 15, 2025Hall Wallace L JRDirectorGrant(A)45K——
Apr 15, 2025O'Brien Stephen PaulPrincipal Accounting OfficerGrant(A)11K——
Apr 15, 2025Wirk ShaheenDirectorGrant(A)176K——
Apr 15, 2025Shah SujalDirectorGrant(A)10K——
Apr 15, 2025Chen YixinVP, Chem, Mfg and CtrlsGrant(A)15K——
Apr 15, 2025Shah SujalDirectorGrant(A)8K——
Apr 15, 2025Wirk ShaheenDirectorGrant(A)263K——
Apr 15, 2025Larson Jeffrey LeroySVP, Research & DevelopmentGrant(A)5K——
Feb 28, 2025Posner ChristopherPRESIDENT AND CEO, DirectorSell(S)583$4.75$3K
Feb 28, 2025Terrillion ScottSEC'Y; CHIEF COMPLIANCE & G.C.Sell(S)163$4.76$776
Feb 4, 2025Posner ChristopherPRESIDENT AND CEO, DirectorSell(S)372$4.72$2K
Nov 4, 2024Posner ChristopherPRESIDENT AND CEO, DirectorSell(S)4K$0.29$1K
Aug 1, 2024Posner ChristopherPRESIDENT AND CEO, DirectorSell(S)4K$0.35$1K
Jun 4, 2024Boudreau Helen MDirectorGrant(A)195K—$0
Jun 4, 2024Boudreau Helen MDirectorGrant(A)151K—$0
Jun 4, 2024Vogelbaum MartinDirectorGrant(A)301K—$0
Jun 4, 2024von Moltke LisaDirectorGrant(A)195K—$0
Jun 4, 2024von Moltke LisaDirectorGrant(A)151K—$0
Jun 4, 2024Ives Jeffrey L.DirectorGrant(A)195K—$0
Jun 4, 2024Ives Jeffrey L.DirectorGrant(A)151K—$0
Jun 4, 2024Shiff Susan Ph.D.DirectorGrant(A)195K—$0
Jun 4, 2024Vogelbaum MartinDirectorGrant(A)390K—$0
Jun 4, 2024Shiff Susan Ph.D.DirectorGrant(A)151K—$0
May 2, 2024Posner ChristopherPRESIDENT AND CEO, DirectorSell(S)4K$0.75$3K
Apr 5, 2024Terrillion ScottSEC'Y; CHIEF COMPLIANCE & G.C.Sell(S)3K$0.83$2K
Apr 5, 2024Goncalves JoanaCHIEF MEDICAL OFFICERSell(S)3K$0.83$2K
Feb 29, 2024Terrillion ScottSEC'Y; CHIEF COMPLIANCE & G.C.Sell(S)3K$0.89$3K
Feb 29, 2024Goncalves JoanaCHIEF MEDICAL OFFICERSell(S)3K$0.89$3K
Feb 29, 2024Posner ChristopherPRESIDENT AND CEO, DirectorSell(S)6K$0.89$5K
Feb 8, 2024Posner ChristopherPRESIDENT AND CEO, DirectorSell(S)36K$0.53$19K
Feb 1, 2024Terrillion ScottSEC'Y; CHIEF COMPLIANCE & G.C.Grant(A)14K—$0
Feb 1, 2024Maynard Ryan DCHIEF FINANCIAL OFFICERGrant(A)14K—$0
Feb 1, 2024Goncalves JoanaCHIEF MEDICAL OFFICERGrant(A)14K—$0
Feb 1, 2024Menzaghi Frederique Ph.D.CHIEF SCIENTIFIC OFF,SVP-R&DGrant(A)14K—$0
Feb 1, 2024Posner ChristopherPRESIDENT AND CEO, DirectorSell(S)5K$0.55$3K
Feb 1, 2024Posner ChristopherPRESIDENT AND CEO, DirectorGrant(A)63K—$0
Nov 2, 2023Posner ChristopherPresident and CEO, DirectorSell(S)4K$1.22$5K
Aug 3, 2023Posner ChristopherPresident and CEO, DirectorSell(S)4K$3.07$13K
Aug 2, 2023Boudreau Helen MDirectorGrant(A)156K—$0
Jun 23, 2023Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DSell(S)3K$3.51$11K
Jun 23, 2023Goncalves JoanaChief Medical OfficerSell(S)3K$3.51$10K
Jun 23, 2023Terrillion ScottSec'y; Chief Compliance & G.C.Sell(S)2K$3.51$9K
Jun 1, 2023Bains Harrison M JRDirectorGrant(A)32K—$0
Jun 1, 2023von Moltke LisaDirectorGrant(A)32K—$0
Jun 1, 2023Shiff Susan Ph.D.DirectorGrant(A)45K—$0
Jun 1, 2023Shiff Susan Ph.D.DirectorGrant(A)32K—$0
Jun 1, 2023Ives Jeffrey L.DirectorGrant(A)45K—$0
Jun 1, 2023Ives Jeffrey L.DirectorGrant(A)32K—$0
Jun 1, 2023Bains Harrison M JRDirectorGrant(A)45K—$0
Jun 1, 2023von Moltke LisaDirectorGrant(A)45K—$0
Jun 1, 2023Vogelbaum MartinDirectorGrant(A)90K—$0
Jun 1, 2023Vogelbaum MartinDirectorGrant(A)65K—$0
May 5, 2023Posner ChristopherPresident and CEO, DirectorSell(S)4K$4.40$17K
Apr 4, 2023Terrillion ScottSec'y; Chief Compliance & G.C.Sell(S)2K$4.91$12K
Apr 4, 2023Goncalves JoanaChief Medical OfficerSell(S)2K$4.91$12K
Apr 4, 2023Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DSell(S)3K$4.91$13K
Mar 3, 2023Goncalves JoanaChief Medical OfficerSell(S)6K$9.71$60K
Mar 3, 2023Terrillion ScottSec'y; Chief Compliance & G.C.Sell(S)6K$9.71$61K
Mar 3, 2023Posner ChristopherPresident and CEO, DirectorSell(S)6K$9.71$58K
Mar 3, 2023Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DSell(S)7K$9.71$66K
Mar 1, 2023Terrillion ScottSec'y; Chief Compliance & G.C.Grant(A)81K—$0
Mar 1, 2023Maynard Ryan DChief Financial OfficerGrant(A)81K—$0
Mar 1, 2023Goncalves JoanaChief Medical OfficerGrant(A)81K—$0
Mar 1, 2023Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DGrant(A)81K—$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Issuer: Cara Therapeutics, Inc., SEC CIK 0001346830. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under CARA and shows every filing by that issuer (also filed as TVRD).

Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).

Keep exploring

Connected pages for CARA